XML 53 R42.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Summary of Significant Segment Expenses

The Company’s significant segment expenses that are regularly provided to the Company’s CODM are as follows:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

(In thousands)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

REVENUES:

 

 

 

 

 

 

 

 

 

 

 

 

Total revenue

 

$

496,009

 

 

$

390,657

 

 

$

888,920

 

 

$

697,167

 

EXPENSES:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)

 

 

98,112

 

 

 

49,460

 

 

 

159,690

 

 

 

98,657

 

External R&D expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Development programs:

 

 

 

 

 

 

 

 

 

 

 

 

Alixorexton

 

 

28,797

 

 

 

23,795

 

 

 

54,294

 

 

 

41,649

 

LYBALVI

 

 

4,939

 

 

 

5,050

 

 

 

9,388

 

 

 

8,901

 

LUMRYZ

 

 

4,710

 

 

 

 

 

 

7,633

 

 

 

 

Other orexin programs

 

 

15,090

 

 

 

2,709

 

 

 

21,944

 

 

 

6,178

 

Other external R&D expenses

 

 

13,832

 

 

 

7,880

 

 

 

24,938

 

 

 

15,384

 

Total external R&D expenses

 

 

67,368

 

 

 

39,434

 

 

 

118,197

 

 

 

72,112

 

Internal R&D expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Employee-related

 

 

37,013

 

 

 

30,651

 

 

 

80,627

 

 

 

62,005

 

Occupancy

 

 

3,335

 

 

 

3,308

 

 

 

6,599

 

 

 

6,455

 

Depreciation

 

 

1,850

 

 

 

1,474

 

 

 

3,537

 

 

 

2,942

 

Other internal R&D expenses

 

 

3,354

 

 

 

2,503

 

 

 

7,305

 

 

 

5,673

 

Total internal R&D expenses

 

 

45,552

 

 

 

37,936

 

 

 

98,068

 

 

 

77,075

 

R&D expenses

 

 

112,920

 

 

 

77,370

 

 

 

216,265

 

 

 

149,187

 

Selling, general and administrative expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing expense

 

 

154,364

 

 

 

121,175

 

 

 

309,276

 

 

 

244,109

 

General and administrative expense

 

 

63,261

 

 

 

49,674

 

 

 

172,942

 

 

 

98,444

 

Total selling, general and administrative expense

 

 

217,625

 

 

 

170,849

 

 

 

482,218

 

 

 

342,553

 

Other segment (expense) income (1)

 

 

(66,851

)

 

 

(5,880

)

 

 

(96,726

)

 

 

2,792

 

NET (LOSS) INCOME

 

 

501

 

 

 

87,098

 

 

 

(65,979

)

 

 

109,562

 

 

(1)
“Other segment (expense) income” during the three and six months ended June 30, 2026 and 2025, includes “Amortization of acquired intangible assets”, “Change in fair value of contingent consideration”, “Total other (expense) income, net” and “Income tax provision (benefit)”.